Clinical Trials Logo

Maternal Death clinical trials

View clinical trials related to Maternal Death.

Filter by:

NCT ID: NCT01945931 Completed - Perinatal Mortality Clinical Trials

Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this trial is to determine if the safe delivery smartphone application distributed to health workers in Ethiopia will decrease perinatal mortality and the incidence of postpartum haemorrhage. It is also the purpose to determine if the safe delivery smartphone application distributed to health workers in Ethiopia will increase health workers knowledge and skills in intra-partum management of active management of third stage labour 2) treatment of post-partum haemorrhage 3) manual removal of placenta and 4) neonatal resuscitation.

NCT ID: NCT01866241 Completed - Clinical trials for Post Partum Hemorrhage

Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage

Start date: November 2012
Phase: Phase 3
Study type: Interventional

Null hypothesis: 10 IU Oxytocin is better than sublingual misoprostol 600µg in management of third stage of labor Alternative hypothesis: Sublingual misoprostol 600µg is non- inferior to 10 IU oxytocin and will not be more than 6% worse [than 10 IU oxytocin] in management of third stage of labor

NCT ID: NCT01699945 Completed - Neonatal Deaths Clinical Trials

Using Ongoing Newborn Intervention Trials to Obtain Additional Data Critical to Maternal, Fetal and Newborn Health in a Harmonized Way

AMANHI
Start date: August 2012
Phase: N/A
Study type: Observational

The goal of this study is to generate unique information to guide improvements on interventions to reduce maternal and newborn mortality as well as prevent stillbirths. The objective of this study is to determine the burden, timing, and causes of maternal deaths, stillbirths and neonatal deaths. This will be an observational study where data will be collected retrospectively in the context of the ongoing study in Haryana, India. Women of reproductive age living in the study area have already been enumerated for the parent studies. Active surveillance is being conducted for identifying pregnancies and deaths among women of reproductive age in the population through 3 monthly home visitations. Verbal autopsies will be conducted for all deaths of women in the reproductive age, including those who died in pregnancy, childbirth and up to 42-60 days after childbirth. Verbal autopsy interviews will also be conducted for all stillbirths.

NCT ID: NCT01571765 Completed - Child Mortality Clinical Trials

MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA

HCUM
Start date: April 2012
Phase: N/A
Study type: Interventional

The investigators will assess whether in Bushenyi District in southwestern Uganda, a two year intervention providing comprehensive MNCH programming will: - Reduce morbidity and mortality for children under five years old and; - Improve access to maternal health services Compared to a control community without MNCH intervention? Hypothesis: Comprehensive maternal, newborn and child health programming in Bushenyi Distrcit can have a positive impact on morbidity and mortality for children under five years and will improve access for women to maternal health services which may lead, in the longer term, to decreased maternal mortality.

NCT ID: NCT01487707 Completed - Maternal Mortality Clinical Trials

Community Based Strategies to Reduce Maternal Mortality in Northern Nigeria

Start date: December 2011
Phase: N/A
Study type: Interventional

The objective of this cluster randomized controlled trial is to assess the impact of several community-based interventions that address the key factors underlying the high maternal mortality, as well as neonatal mortality and morbidity in northern Nigeria. The interventions, include: 1. a Voluntary Health Worker Program (VHW) 2. the VHW program with provision of a safe birth kit 3. the VHW program with community folk media activities.

NCT ID: NCT01389219 Completed - Neonatal Mortality Clinical Trials

Post Partum Maternal and Neonatal Intervention Package

Start date: October 2007
Phase: N/A
Study type: Interventional

Introduction of a community-based intervention package including prevention strategies, early recognition and management of common postpartum & neonatal problems, as well as prompt referral of high risk/complicated cases through trained first level primary health care workers, will result in a significant reduction in Postpartum maternal and neonatal mortality in Pakistan

NCT ID: NCT00211341 Completed - Clinical trials for Vitamin A Deficiency

Trial of the Impact of Vitamin A on Maternal Mortality

ObaapaVitA
Start date: December 2000
Phase: Phase 3
Study type: Interventional

Main objectives: To evaluate the impact of weekly vitamin A supplementation (VAS) to women of reproductive age (15-45 years) on maternal mortality in rural Ghana, and to compare this with the impact on overall mortality. Hypotheses: 1. Weekly supplementation with vitamin A (7000 µg retinol equivalent [RE]) to reproductive age women will reduce maternal deaths by 33%. 2. This impact will be achieved by reductions in both pregnancy-related and non-pregnancy-related deaths. 3. There will be a reduction in non-maternal deaths, similar in size to that in maternal non-pregnancy related deaths. Outcome measures: Maternal mortality rate, and overall mortality rate. Deaths will be identified through monthly demographic surveillance, and classified as maternal (pregnancy-related, non-pregnancy-related) or non-maternal using verbal autopsies.

NCT ID: NCT00198822 Completed - Clinical trials for Vitamin A Deficiency

Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.